BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21311234)

  • 1. SAHF, to senesce or not to senesce?
    Kocylowski MK; Halazonetis TD
    Cell Cycle; 2011 Mar; 10(5):738-9. PubMed ID: 21311234
    [No Abstract]   [Full Text] [Related]  

  • 2. Senescence-associated heterochromatin foci are dispensable for cellular senescence, occur in a cell type- and insult-dependent manner and follow expression of p16(ink4a).
    Kosar M; Bartkova J; Hubackova S; Hodny Z; Lukas J; Bartek J
    Cell Cycle; 2011 Feb; 10(3):457-68. PubMed ID: 21248468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromatin remodeling, BRCA1, SAHF and cellular senescence.
    Tu Z; Aird KM; Zhang R
    Cell Cycle; 2013 Jun; 12(11):1653-4. PubMed ID: 23673322
    [No Abstract]   [Full Text] [Related]  

  • 4. Interferon-gamma induces cellular senescence through p53-dependent DNA damage signaling in human endothelial cells.
    Kim KS; Kang KW; Seu YB; Baek SH; Kim JR
    Mech Ageing Dev; 2009 Mar; 130(3):179-88. PubMed ID: 19071156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer.
    Di Micco R; Sulli G; Dobreva M; Liontos M; Botrugno OA; Gargiulo G; dal Zuffo R; Matti V; d'Ario G; Montani E; Mercurio C; Hahn WC; Gorgoulis V; Minucci S; d'Adda di Fagagna F
    Nat Cell Biol; 2011 Mar; 13(3):292-302. PubMed ID: 21336312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global reorganization of the nuclear landscape in senescent cells.
    Chandra T; Ewels PA; Schoenfelder S; Furlan-Magaril M; Wingett SW; Kirschner K; Thuret JY; Andrews S; Fraser P; Reik W
    Cell Rep; 2015 Feb; 10(4):471-83. PubMed ID: 25640177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleolar aggresomes mediate release of pericentric heterochromatin and nuclear destruction of genotoxically treated cancer cells.
    Salmina K; Huna A; Inashkina I; Belyayev A; Krigerts J; Pastova L; Vazquez-Martin A; Erenpreisa J
    Nucleus; 2017 Mar; 8(2):205-221. PubMed ID: 28068183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redistribution of the Lamin B1 genomic binding profile affects rearrangement of heterochromatic domains and SAHF formation during senescence.
    Sadaie M; Salama R; Carroll T; Tomimatsu K; Chandra T; Young AR; Narita M; Pérez-Mancera PA; Bennett DC; Chong H; Kimura H; Narita M
    Genes Dev; 2013 Aug; 27(16):1800-8. PubMed ID: 23964094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p16INK4a-induced senescence is disabled by melanoma-associated mutations.
    Haferkamp S; Becker TM; Scurr LL; Kefford RF; Rizos H
    Aging Cell; 2008 Oct; 7(5):733-45. PubMed ID: 18843795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16(INK4a) and the control of cellular proliferative life span.
    Huschtscha LI; Reddel RR
    Carcinogenesis; 1999 Jun; 20(6):921-6. PubMed ID: 10357768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent DNA damage-induced premature senescence alters the functional features of human bone marrow mesenchymal stem cells.
    Minieri V; Saviozzi S; Gambarotta G; Lo Iacono M; Accomasso L; Cibrario Rocchietti E; Gallina C; Turinetto V; Giachino C
    J Cell Mol Med; 2015 Apr; 19(4):734-43. PubMed ID: 25619736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p16INK4a in cellular senescence.
    Simboeck E; Di Croce L
    Aging (Albany NY); 2013 Aug; 5(8):590-1. PubMed ID: 23965734
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation.
    Narita M; Narita M; Krizhanovsky V; Nuñez S; Chicas A; Hearn SA; Myers MP; Lowe SW
    Cell; 2006 Aug; 126(3):503-14. PubMed ID: 16901784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular dissection of formation of senescence-associated heterochromatin foci.
    Zhang R; Chen W; Adams PD
    Mol Cell Biol; 2007 Mar; 27(6):2343-58. PubMed ID: 17242207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the INK4a/Arf gene locus in senescence.
    Collins CJ; Sedivy JM
    Aging Cell; 2003 Jun; 2(3):145-50. PubMed ID: 12882406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy.
    Schmitt CA; Fridman JS; Yang M; Lee S; Baranov E; Hoffman RM; Lowe SW
    Cell; 2002 May; 109(3):335-46. PubMed ID: 12015983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMI-1026 treatment can induce SAHF formation by activation of Erk1/2.
    Seo HJ; Park HJ; Choi HS; Hwang SY; Park JS; Seong YS
    BMB Rep; 2008 Jul; 41(7):523-8. PubMed ID: 18682036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogene-induced senescence pathways in melanocytes.
    Haferkamp S; Rizos H
    Cell Cycle; 2010 Dec; 9(24):4778-9. PubMed ID: 21150332
    [No Abstract]   [Full Text] [Related]  

  • 19. Vulnerability to oxidative stress and different patterns of senescence in human peritoneal mesothelial cell strains.
    Ksiazek K; Mikula-Pietrasik J; Olijslagers S; Jörres A; von Zglinicki T; Witowski J
    Am J Physiol Regul Integr Comp Physiol; 2009 Feb; 296(2):R374-82. PubMed ID: 19036828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remodeling of chromatin structure in senescent cells and its potential impact on tumor suppression and aging.
    Adams PD
    Gene; 2007 Aug; 397(1-2):84-93. PubMed ID: 17544228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.